STERIS announces financial results for fiscal 2027 first quarter
Revenue increased 7% to $1.5 billion; adjusted EPS rose to $2.59; company reiterates fiscal 2027 outlook and announces restructuring plan.
See the latest news and media coverage for STERIS. We track all announcements, press releases, and industry mentions in real time, all in one place.
Infection prevention and patient care products and services provider
steris.comLast updated
In short: STERIS announced a $600 million investment in North Carolina and reported a 7% revenue increase for the first quarter of fiscal 2027.
Revenue increased 7% to $1.5 billion; adjusted EPS rose to $2.59; company reiterates fiscal 2027 outlook and announces restructuring plan.
The new 600,000-square-foot campus will create 335 jobs and support sterilization and disinfection for healthcare and pharmaceutical industries, becoming the largest single-site investment in company history.
The quarterly interim dividend increase of $0.06 marks the 21st consecutive year of growth.
Revenue increased 9% and adjusted EPS rose to $10.17, with a new $1 billion share repurchase program.
STERIS plc stock is supported by a 7% revenue increase in fiscal 2027 first-quarter results and a recent NYSE quote near its 52-week range.
The end of the earnings season is always a good time to take a step back and see who shined (and who didn't). Let's take...
STERIS plc (NYSE: STE) ("STERIS" or the "Company") today announced financial results for its fiscal 2027 first quarter ended June 30, 2026. Total revenue for...
STE is betting $600 million on a new chemistry center to boost capacity and efficiency, but higher...
Track STERIS and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to STERIS and other trending companies.